We have to trust that Dr.M knows what he is doing.
Yes, we must.
Consider, who has the most to lose if Anavex goes bust on blarcamesine? Personally, I’ve got a very moderate fraction of my disposable, discretionary investment dollars tied up in AVXL. I sure don’t want to lose them. But if Missling can’t get blarcamesine approved anywhere for therapeutic uses and sales, I’ve lost my dollars.
Should that happen (it won’t), how many dollars will Missling himself have lost?
In stock investing, “insider buying” of an equity, where company insiders buy shares of their company, is always a very positive message. If insiders buy, they do this with information that is not so available to “outsiders.”
Missling, in the past, has done some inside buying. Positive enough. But presently, he doesn’t have to buy more AVXLs. He’s got a pile of them already, and apparently, options to buy more at the right time (at the right price). Simply, he’s already “fully committed” to making Anavex a success. If he succeeds, if blarcamesine gets approved, he will be exceedingly wealthy. If he fails, well....
Missling has my interests in mind when he makes executive decisions. In fact, we share those interests—make blarcamesine a success. Because of what’s at stake for him, he will make no cavalier decisions or fail to act. For him, everything’s at stake.
And, the Anavex science supports all that he’s aiming at. Anavex and blarcamesine are not blind shots in the dark. No shots at all. Blarcamesine will be taken by swallowing a pill, with a glass of water. Thereafter, it will work its wonders.
News 
Market Data 
Discover 
